Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: June 22, 2005
Event: Entry into a Material Definitive Agreement regarding a contract amendment with the United Kingdom's National Health Service (NHS).
Key Financial Metrics
This filing reports a specific transactional event rather than periodic financial performance. Consequently, standard metrics such as revenue, profit, cash flow, margins, debt, and liquidity for a reporting period are not provided in this document.
- Transaction Value: Cash payment of GBP 78.8 million (approximately US$143 million) from the NHS to McKesson.
- Contract Term Extension: 30-month extension to the original 10-year contract.
Material Changes
The filing details a material amendment to an existing contract for an integrated Electronic Staff Record system. Key changes include:
- Extension of the contract term by 30 months.
- Receipt of a lump-sum cash payment primarily compensating the Company for investments made in the project to date.
- Adoption of an updated implementation plan.
Guidance, Outlook, and Risks
Management Commentary: The signed amendment contains terms substantially similar to the tentative agreement previously disclosed in the Company's Form 10-K for the fiscal year ended March 31, 2005.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the execution of the amended agreement terms.
Investor Verification Checklist
- Verify the impact of the US$143 million cash receipt on the Company's current quarter cash flow and earnings.
- Review the updated implementation plan for the Electronic Staff Record system to assess future operational risks.
- Confirm the accounting treatment of the GBP 78.8 million payment (e.g., revenue recognition vs. asset recovery) in upcoming financial statements.
- Compare the final signed terms against the tentative agreement disclosed in the March 31, 2005 Form 10-K for any material deviations.